INCREASING EFFICIENCY OF VENTILATION IN COVID-19. The Alginate oligosaccharide OligoG CF-5/20 may be an immediate low risk trial Covid-19.

UPDATE: AUSTRALIAN DRUG TRIAL / AlgiPharma AS Immediate available drug for Cystic Fibrosis could be utilized to save lives in Covid-19 crisis.The Alginate oligosaccharide OligoG CF-5/20 may be an immediate low risk trial Covid-19. It is a drug being tested for Cystic Fibrosis. It is currently in Clinical Trials. Can this help in Ventilator Therapy and Decrease Deaths and Time …